OTCMKTS:TEAR TearLab (TEAR) Stock Price, News & Analysis $0.06 0.00 (-1.86%) As of 07/9/2020 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About TearLab Stock (OTCMKTS:TEAR) Get TearLab alerts:Sign Up Key Stats Today's Range$0.06▼$0.0650-Day Range$0.06▼$0.0652-Week Range$0.02▼$0.22Volume20,200 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview TearLab Corporation is a specialty diagnostics company focused on the development, manufacturing and commercialization of point‐of‐care diagnostic solutions for dry eye disease. Its flagship offering, the TearLab Osmolarity System, employs proprietary microfluidic technology to measure tear film osmolarity from a single tear sample. The system delivers quantitative results within minutes, enabling eye care professionals to make more informed diagnostic and treatment decisions in a clinical setting. In addition to its core osmolarity platform, TearLab provides single‐use test cards and related consumables designed for ease of use and rapid workflow integration. The company’s products target a range of ophthalmology and optometry practices, offering a standardized approach to dry eye assessment. Distribution channels include a combination of direct sales in the United States and a network of distributors serving markets in Europe, Asia and Latin America, reflecting TearLab’s efforts to build a global footprint in the eye health diagnostics sector. Founded in 2003 and headquartered in San Diego, California, TearLab has collaborated with clinical researchers and key opinion leaders to validate the clinical utility of tear osmolarity measurements. The company’s management team brings experience in medical device innovation, commercial operations and regulatory affairs, positioning TearLab to address the growing demand for objective and reproducible dry eye disease diagnostics worldwide.AI Generated. May Contain Errors. Read More Receive TEAR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TearLab and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TEAR Stock News HeadlinesHarrow Announces New Appointments to its Board of DirectorsJanuary 29, 2024 | finance.yahoo.comSTRATA Skin Science Announces Leadership ChangeOctober 30, 2023 | benzinga.comBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.May 25 at 1:00 AM | Weiss Ratings (Ad)Ocular Therapeutix™ Announces Appointment of New Board MemberJuly 12, 2023 | finance.yahoo.comOcular Allergy Diagnostic Systems Market Size 2023 with End-user Industries, Segments Covered in the ReportJanuary 15, 2023 | marketwatch.comHousing Authority officials want more police help at East AcresSeptember 9, 2022 | yahoo.comLawrence schools on 'good footing' financiallySeptember 9, 2022 | yahoo.comPathway Makes Four Senior PromotionsSeptember 9, 2022 | nz.finance.yahoo.comSee More Headlines TEAR Stock Analysis - Frequently Asked Questions How have TEAR shares performed this year? TearLab's stock was trading at $0.0579 on January 1st, 2026. Since then, TEAR shares have increased by 0.0% and is now trading at $0.0579. How were TearLab's earnings last quarter? TearLab Corporation (OTCMKTS:TEAR) posted its quarterly earnings results on Thursday, August, 8th. The medical research company reported ($0.10) earnings per share for the quarter. The medical research company had revenue of $5.85 million for the quarter. When did TearLab's stock split? Shares of TearLab reverse split on Friday, February 24th 2017.The 1-10 reverse split was announced on Friday, February 24th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 23rd 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of TearLab? Shares of TEAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of TearLab own? Based on aggregate information from My MarketBeat watchlists, some other companies that TearLab investors own include Protalix BioTherapeutics (PLX), SCYNEXIS (SCYX), CorMedix (CRMD) and Rigel Pharmaceuticals (RIGL). Company Calendar Last Earnings8/08/2019Today5/25/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolOTCMKTS:TEAR Previous SymbolNASDAQ:TEAR CIK1299139 Webwww.tearlab.com Phone858-455-6006Fax858-812-0540Employees34Year Founded2003Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free Report This page (OTCMKTS:TEAR) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TearLab Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share TearLab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
